Sweden · Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 36.09 billion. The enterprise value is 50.94 billion.
| Market Cap | 36.09B |
| Enterprise Value | 50.94B |
Important Dates
The next confirmed earnings date is Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Apr 30, 2026 |
Share Statistics
Medicover AB has 151.97 million shares outstanding. The number of shares has increased by 0.58% in one year.
| Current Share Class | 75.42M |
| Shares Outstanding | 151.97M |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 11.52% |
| Owned by Institutions (%) | 26.32% |
| Float | 52.98M |
Valuation Ratios
The trailing PE ratio is 41.14 and the forward PE ratio is 30.08. Medicover AB's PEG ratio is 0.42.
| PE Ratio | 41.14 |
| Forward PE | 30.08 |
| PS Ratio | 1.36 |
| PB Ratio | 5.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.02 |
| P/OCF Ratio | 10.00 |
| PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.59, with an EV/FCF ratio of 26.85.
| EV / Earnings | 58.40 |
| EV / Sales | 1.92 |
| EV / EBITDA | 12.59 |
| EV / EBIT | 27.70 |
| EV / FCF | 26.85 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 2.51.
| Current Ratio | 0.74 |
| Quick Ratio | 0.65 |
| Debt / Equity | 2.51 |
| Debt / EBITDA | 3.86 |
| Debt / FCF | 8.22 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is 13.86% and return on invested capital (ROIC) is 6.51%.
| Return on Equity (ROE) | 13.86% |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 6.51% |
| Return on Capital Employed (ROCE) | 9.65% |
| Weighted Average Cost of Capital (WACC) | 9.75% |
| Revenue Per Employee | 542,865 |
| Profits Per Employee | 17,803 |
| Employee Count | 49,000 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 28.98 |
Taxes
In the past 12 months, Medicover AB has paid 289.68 million in taxes.
| Income Tax | 289.68M |
| Effective Tax Rate | 26.16% |
Stock Price Statistics
The stock price has decreased by -9.18% in the last 52 weeks. The beta is 1.50, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -9.18% |
| 50-Day Moving Average | 212.16 |
| 200-Day Moving Average | 220.39 |
| Relative Strength Index (RSI) | 72.54 |
| Average Volume (20 Days) | 65,625 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 26.60 billion and earned 872.34 million in profits. Earnings per share was 5.77.
| Revenue | 26.60B |
| Gross Profit | 6.20B |
| Operating Income | 1.84B |
| Pretax Income | 1.11B |
| Net Income | 872.34M |
| EBITDA | 2.96B |
| EBIT | 1.84B |
| Earnings Per Share (EPS) | 5.77 |
Balance Sheet
The company has 945.86 million in cash and 15.59 billion in debt, with a net cash position of -14.65 billion or -96.38 per share.
| Cash & Cash Equivalents | 945.86M |
| Total Debt | 15.59B |
| Net Cash | -14.65B |
| Net Cash Per Share | -96.38 |
| Equity (Book Value) | 6.21B |
| Book Value Per Share | 39.78 |
| Working Capital | -1.94B |
Cash Flow
In the last 12 months, operating cash flow was 3.61 billion and capital expenditures -1.71 billion, giving a free cash flow of 1.90 billion.
| Operating Cash Flow | 3.61B |
| Capital Expenditures | -1.71B |
| Depreciation & Amortization | 1.13B |
| Net Borrowing | 768.84M |
| Free Cash Flow | 1.90B |
| FCF Per Share | 12.48 |
Margins
Gross margin is 23.31%, with operating and profit margins of 6.91% and 3.28%.
| Gross Margin | 23.31% |
| Operating Margin | 6.91% |
| Pretax Margin | 4.16% |
| Profit Margin | 3.28% |
| EBITDA Margin | 11.14% |
| EBIT Margin | 6.91% |
| FCF Margin | 7.13% |
Dividends & Yields
This stock pays an annual dividend of 2.21, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 2.21 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | 32.24% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 28.30% |
| Buyback Yield | -0.58% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 2.42% |
| FCF Yield | 5.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Medicover AB is 262.67, which is 13.96% higher than the current price. The consensus rating is "Buy".
| Price Target | 262.67 |
| Price Target Difference | 13.96% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 11.80% |
| EPS Growth Forecast (3Y) | 23.17% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.28 |
| Piotroski F-Score | 6 |